{"result": "(\"entity\"<|>PTHrP<|>PERSON<|>PTHrP is a hormone that acts in the body to increase calcium reabsorption in the kidneys and bone resorption, often associated with malignancy-related hypercalcemia.)\n##\n(\"entity\"<|>HYPERCALCEMIA<|>EVENT<|>Hypercalcemia is a condition characterized by an abnormally high level of calcium in the blood, often associated with certain cancers.)\n##\n(\"entity\"<|>CANCER<|>EVENT<|>Cancer is a disease in which abnormal cells divide uncontrollably and can invade nearby tissues, often leading to various health complications including hypercalcemia.)\n##\n(\"entity\"<|>HYPERPARATHYROIDISM<|>EVENT<|>Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone, leading to elevated calcium levels in the blood.)\n##\n(\"entity\"<|>EL-HAJJ FULEIHAN<|>PERSON<|>El-Hajj Fuleihan is a researcher who has contributed to the understanding of primary hyperparathyroidism and its diagnosis.)\n##\n(\"entity\"<|>SILVERBERG<|>PERSON<|>Silverberg is a researcher who has worked on hypercalcemia of malignancy and its mechanisms.)\n##\n(\"entity\"<|>MELMED<|>PERSON<|>Melmed is an author of the Williams Textbook of Endocrinology, which discusses various endocrine disorders including hyperparathyroidism.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides evidence-based information on various medical topics, including hyperparathyroidism and hypercalcemia.)\n##\n(\"entity\"<|>GAMMAGRAFÍA CON SESTAMIBI<|>EVENT<|>Gammagraphy with sestamibi is a diagnostic imaging technique used to locate parathyroid adenomas in patients suspected of having hyperparathyroidism.)\n##\n(\"entity\"<|>TAC<|>EVENT<|>TAC, or computed tomography, is an imaging technique that can be used in conjunction with sestamibi scans to improve localization of parathyroid adenomas.)\n##\n(\"entity\"<|>NODULOS TIROIDEOS<|>EVENT<|>Thyroid nodules are growths in the thyroid gland that can complicate the diagnosis of parathyroid adenomas.)\n##\n(\"relationship\"<|>PTHrP<|>HYPERCALCEMIA<|>PTHrP is often secreted by tumors leading to hypercalcemia in patients with malignancies<|>8)\n##\n(\"relationship\"<|>HYPERCALCEMIA<|>CANCER<|>Hypercalcemia is commonly associated with various types of cancer, particularly solid tumors<|>7)\n##\n(\"relationship\"<|>HYPERPARATHYROIDISM<|>HYPERCALCEMIA<|>Hyperparathyroidism is a common cause of hypercalcemia, leading to elevated calcium levels in the blood<|>8)\n##\n(\"relationship\"<|>EL-HAJJ FULEIHAN<|>UPTODATE<|>El-Hajj Fuleihan has contributed to the UpToDate resource on primary hyperparathyroidism<|>6)\n##\n(\"relationship\"<|>SILVERBERG<|>UPTODATE<|>Silverberg has contributed to the UpToDate resource on hypercalcemia of malignancy<|>6)\n##\n(\"relationship\"<|>MELMED<|>UPTODATE<|>Melmed is an author referenced in UpToDate for information on endocrine disorders<|>6)\n##\n(\"relationship\"<|>GAMMAGRAFÍA CON SESTAMIBI<|>HYPERPARATHYROIDISM<|>Gammagraphy with sestamibi is used to locate adenomas in patients with suspected hyperparathyroidism<|>7)\n##\n(\"relationship\"<|>TAC<|>GAMMAGRAFÍA CON SESTAMIBI<|>TAC is used in conjunction with gammagraphy to improve the localization of parathyroid adenomas<|>6)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>GAMMAGRAFÍA CON SESTAMIBI<|>Thyroid nodules can complicate the interpretation of gammagraphy with sestamibi in locating parathyroid adenomas<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: de la reabsorción renal de calcio.\nD. La PTHrP actúa habitualmente mediante la unión a un receptor diferente al de la PTH.\n\nCOMENTARIO\n\nLas primeras acciones identificadas de la PTHrP fueron acciones pseudo-PTH asociadas a la hipercalcemia humoral del cáncer, que representa hasta el 80% de los pacientes con hipercalcemia de malignidad. En esta entidad patológica, la PTHrP actúa como hormona: el tumor la segrega al torrente sanguíneo y actúa en el hueso (aumenta la resorción ósea) y en el riñón (reabsorción del calcio) por lo que sube la concentración de calcio.\n\nEn muchas acciones, la PTHrP actúa a través del receptor PTH/PTHrP que es el mismo de la PTH e imita todas las acciones de los fragmentos amino-terminales de la PTH (opción D falsa: respuesta correcta). La concentración sanguínea de PTHrP es alta en la mayoría\n\nde los pacientes con tumores sólidos e hipercalcemia y suprime la secreción de PTH, su concentración es muy baja o indetectable. La 1,25 (OH)2D3 es normal o baja.\n\nEs la causa más común de hipercalcemia en pacientes con tumores sólidos no metastásicos y en algunos pacientes con linfoma no Hodgkin. Por lo general, tienen una enfermedad avanzada y un mal pronóstico.\n\nLos tumores asociados con más frecuencia a hipercalcemia tumoral son: cáncer epidermoide pulmonar, de cabeza y cuello, esofágico, de cuello uterino bulbar y espinocelular cutáneo; cáncer de mama, cáncer renal y cáncer vesical. Los feocromocitomas benignos o malignos, los tumores de células de los islotes y los carcinoides pueden producir también un exceso de PTHrP que causa hipercalcemia. El linfoma de linfocitos T agresivo asociado a la infección por el virus linfótropo de linfocitos T humano de tipo 1 (HTLV-1) es el único cáncer hematológico asociado a la producción excesiva de PTHrP.\n\nReferencias:\n- El-Hajj Fuleihan G, Silverberg SJ. Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation. Rosen CJ, ed. UptoDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso 6 de junio de 2019).\n- Horwitz MJ. Hypercalcemia of malignancy: Mechanisms. Rosen CJ, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso 7 de junio de 2019).\n- Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016.\n\n## 6 Le envían a consulta una paciente de 55 años para valoración de hipercalcemia. Como antecedente destaca un bocio multinodular eutiroideo, dado de alta del servicio hace años tras varias ecografías sin crecimiento nodular. Analítica actual: calcio, 11,8 mg/dl (8,5-10,4 mg/dl); fósforo, 2,1 mg/dl (2,4-4,9 mg/dl); PTH, 76 pg/ml (10-55 pg/ml); vitamina D, 33 ng/ml (suficiencia mayor de 30 ng/ml); calciuria, 405 mg/24 h. No hay antecedentes familiares de hipercalcemia. Usted cree que la paciente tiene un hiperparatiroidismo primario (HPP) y considera que tiene criterios quirúrgicos. Antes de derivar a cirugía pide como prueba de imagen localizadora una gammagrafía con sestamibi, pero el resultado es negativo. Señale cuál de las siguientes afirmaciones es falsa:\n\nA. Una gammagrafía con sestamibi negativa no excluye el diagnóstico de HPP, puesto que ocurre en el 12-25% de los pacientes.\nB. Los resultados del sestamibi pueden mejorarse si: 1) se combina con imágenes en tres dimensiones (Sestamibi-Single Photon Emision Computed Tomography: SPECT), 2) se realiza una gammagrafía tiroidea y se practica una sustracción de imágenes o 3) se realiza una fusión con imágenes de TAC (MIBI-SPECT-TAC).\nC. La ecografía es a menudo usada para localización, y presenta como ventaja una mayor sensibilidad para localizar adenomas paratiroideos en pacientes con nódulos tiroideos.\nD. La no localización del adenoma mediante pruebas de imagen no es criterio para no indicar la intervención si cumple criterios quirúrgicos. En estos casos debe realizarse exploración bilateral por un cirujano con experiencia.\n---\n# METABOLISMO FOSFOCÁLCICO, TUMORES NE\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}